Altria Group Plans to Sell 35 Million Shares of AB InBev

Business by 2FIRSTS.ai

Mar.15.2024

Altria Group Plans to Sell 35 Million Shares of AB InBev

Altria Group plans to sell 35 million shares of Anheuser-Busch InBev for $2.26 billion, reducing its stake to 10%.

According to Reuters on March 14th, Altria Group plans to sell 35 million shares of Anheuser-Busch InBev. Altria currently owns approximately 197 million shares of Anheuser-Busch InBev, representing a 10% stake in the company.

On the recent stock market closing day, the total value of this equity sale was $2.26 billion. Anheuser-Busch InBev plans to sell a portion of its American depositary shares of Budweiser in the United States, as well as conduct a private placement in the European Economic Area and the United Kingdom.

Altria Group announced that Anheuser-Busch InBev has agreed to repurchase $2 billion worth of common stock directly from Altria after the equity offering concludes.

Altria Group owns several tobacco brands including Marlboro and the vape company NJOY, while Anheuser-Busch InBev is one of the largest beer producers in the world, headquartered in Belgium. It was formed by the merger of Anheuser-Busch and InBev in 2008. The company operates multiple well-known beer brands such as Budweiser, Corona, Stella Artois, and Hoegaarden. Anheuser-Busch InBev holds a significant market share globally and continues to expand its business operations.

References:

[1] Tobacco firm Altria to sell some AB InBev shares

Also Read:

[1] Altria Applies to FDA for Selling NJOY Fruit Flavors in 100,000 Stores by 2024

[2] Altria Releases Financial Report for Q4 2023 and Full Year, Net Revenue Reaching $24.48 Billion for 2023

[3] Altria Group's Q4 Earnings Impacted by Declining Cigarette Sales

#Europe #Traditional tobacco #Belgium #Major companies

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

BAT accused of “utter hypocrisy” over efforts to dilute Zambia’s tobacco bill

The Guardian reports that British American Tobacco urged Zambian ministers to drop or delay ad and sponsorship bans and to soften a draft tobacco bill by shrinking health warnings, easing flavour restrictions and lowering penalties. Critics said the stance is hypocritical given similar rules apply in the UK.

Nov.13

AIR Acquires Germany’s NameLess to Expand Global Presence in Flavored Hookah Market

AIR Limited, the Dubai-based global leader in hookah and advanced inhalation technologies, announced the acquisition of NameLess, one of Germany’s most recognized brands for premium flavored hookah products.

Dec.11 by 2FIRSTS.ai

NSW Landlords Could Face Jail or $165,000 Fine for Allowing Illegal Vape and Tobacco Sales

According to The Guardian, landlords in New South Wales who knowingly allow tenants to sell illicit tobacco or illegal vapes could face fines of up to AUD 165,000, a year in prison, or both. The new offences are part of the state government’s broader crackdown on Australia’s growing black market for cigarettes and vaping products.

Nov.12 by 2FIRSTS.ai

U.S. vape firms appeal Mississippi synthetic-nicotine ban, citing FDA authority preemption

A coalition of U.S. vape industry groups has appealed a Mississippi law banning the sale of e-cigarette products containing synthetic nicotine, arguing the statute effectively conditions sales on FDA authorization and unlawfully encroaches on federal regulatory authority. The law took effect in July 2025 and has already begun to be enforced.